Biohaven Pharmaceuticals is a clinical/commercial-stage biopharmaceutical company located in New Haven, CT that is engaged in developing a portfolio of innovative, late-stage therapeutic candidate molecules that target, neurological and neuropsychiatric diseases, including rare disorders. They have new programs that reach into areas including migraine headache, inflammation and neurodegeneration.
Biohaven runs a novel summer internship program for undergraduate and graduate students who are interested in the evaluation of new therapeutics and the process of identifying new intellectual property that may have marketplace value. Biohaven will work with the intern to identify an aspect of the drug development process where the student can participate in Biohaven’s work. Applicants should submit a letter of interest, their transcripts, and a resume or C.V. to the department of Molecular and Cell Biology (firstname.lastname@example.org) for evaluation. Applications are due April 1, 2020.